The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma

NAActive, not recruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Endometrial Neoplasms
Interventions
PROCEDURE

TH

Total hysterectomy

PROCEDURE

TH/BSO

Total hysterectomy and bilateral salpingo-oophorectomy

PROCEDURE

BPLND

bilateral pelvic and para-aortic lymph node dissection

Trial Locations (3)

250012

Qilu Hospital,Shandong University, Jinan

310006

Women's Hospital, School of Medicine, Zhejiang University, Hangzhou

430030

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
collaborator

Shandong University

OTHER

collaborator

Huazhong University of Science and Technology

OTHER

collaborator

Zhejiang University

OTHER

lead

Ding Ma

OTHER

NCT01820884 - The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma | Biotech Hunter | Biotech Hunter